Methods of treatment

Details for Australian Patent Application No. 2009228163 (hide)

Owner GlaxoSmithKline LLC

Inventors Ventresca, Giampietro; Hargreave, Fredrick E.

Agent Davies Collison Cave

Pub. Number AU-B-2009228163

PCT Pub. Number WO2009/120927

Priority 61/040,363 28.03.08 US

Filing date 27 March 2009

Wipo publication date 1 October 2009

Acceptance publication date 30 August 2012

International Classifications

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/120927 Priority application(s): WO2009/120927

30 August 2012 Application Accepted

  Published as AU-B-2009228163

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228165-Method for amplifying locus in bacterial cell

2009228158-Compositions and methods for inhibiting PDGFRbeta and VEGF-A